Inventor
FLAVELL RICHARD
US32 patents
⚠️ This page may combine multiple inventors who share the name “FLAVELL RICHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
17 patentsUS10433527B2Oct 8, 2019
Genetically modified non-human animals and methods of use thereof
REGENERON PHARMA13 citations92
US9986724B2Jun 5, 2018
Genetically modified non-human animals and methods of use thereof
REGENERON PHARMA17 citations92
US9901082B2Feb 27, 2018
Genetically modified non-human animals and methods of use thereof
REGENERON PHARMA17 citations92
US9820476B2Nov 21, 2017
Genetically modified non-human animals and methods of use thereof
REGENERON PHARMA12 citations92
US9655352B2May 23, 2017
Humanized M-CSF mice
REGENERON PHARMA19 citations92
US9554563B2Jan 31, 2017
Genetically modified mice and engraftment
REGENERON PHARMA20 citations92
US11051499B2Jul 6, 2021
Genetically modified mice and engraftment
REGENERON PHARMA3 citations83
US10278374B2May 7, 2019
Genetically modified mice and engraftment
REGENERON PHARMA3 citations83
US11026408B2Jun 8, 2021
Genetically modified non-human animals and methods of use thereof
REGENERON PHARMA2 citations72
US12402611B2Sep 2, 2025
Genetically modified mice and engraftment
REGENERON PHARMA0 citations62
US12127537B2Oct 29, 2024
Genetically modified non-human animals and methods of use thereof
REGENERON PHARMA0 citations62
US12127536B2Oct 29, 2024
Humanized M-CSF mice
REGENERON PHARMA0 citations62
US11766032B2Sep 26, 2023
Genetically modified non-human animals expressing human EPO
REGENERON PHARMA0 citations62
US10463028B2Nov 5, 2019
Genetically modified non-human animals expressing human EPO
REGENERON PHARMA1 citations62
US11778995B2Oct 10, 2023
Genetically modified non-human animals and methods of use thereof
REGENERON PHARMA0 citations61
US10785966B2Sep 29, 2020
Humanized M-CSF mice
REGENERON PHARMA0 citations51
US10785968B2Sep 29, 2020
Genetically modified non-human animals and methods of use thereof
REGENERON PHARMA0 citations50
UNIV YALE
5 patentsUS10428392B2Oct 1, 2019
Compositions and methods for identifying secretory antibody-bound microbes
UNIV YALE4 citations82
US9758838B2Sep 12, 2017
Compositions and methods for identifying secretory antibody-bound microbes
UNIV YALE6 citations82
US10925953B2Feb 23, 2021
Compositions and methods for treating an inflammatory disease or disorder
UNIV YALE2 citations71
US10774392B2Sep 15, 2020
Compositions and methods for identifying secretory antibody-bound microbes
UNIV YALE1 citations71
US11299790B2Apr 12, 2022
Compositions and methods for identifying secretory antibody-bound microbes
UNIV YALE0 citations60
CERES INC
5 patentsUS10822616B2Nov 3, 2020
Transgenic plants having altered biomass composition
CERES INC1 citations72
US12584142B2Mar 24, 2026
Transgenic plants having altered biomass composition
CERES INC0 citations62
US11299747B2Apr 12, 2022
Transgenic plants having altered biomass composition
CERES INC0 citations59
US10815496B2Oct 27, 2020
Transgenic plants having altered biomass composition
CERES INC0 citations51
US10323256B2Jun 18, 2019
Transgenic plants having altered biomass composition
CERES INC0 citations48